Liposarcoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (15 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Liposarcoma}} | {{Liposarcoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{Ammu}}; {{AL}}{{Sab}} | ||
==Overview== | ==Overview== | ||
[[Positron emission tomography|Positron emission tomography (PET) scan]] is useful in cases where the liposarcoma is firm, deep, and has a size greater than 3 cm. [[Positron emission tomography|PET scan]] may also help evaluate the [[Grading (tumors)|grade]] and [[prognosis]] of the [[tumor]], as well as its shrinkage following [[chemotherapy]]. | |||
=== | ==Other Imaging Findings== | ||
===Positron emission tomography (PET)=== | |||
* [[Positron emission tomography|Positron emission tomography (PET]]) is useful to evaluate cases of liposarcoma, especially when the [[tumor]] is firm, deep, and has a size greater than 3 cm.<ref name="NCCN">{{cite web | title = NCCN Guidelines for Patients - Soft Tissue Sarcoma | url =http://www.nccn.org/patients/guidelines/sarcoma/index.html#2 }}</ref> | |||
* [[Positron emission tomography|PET scan]] is also useful to evaluate: | |||
**[[Tumor]] [[Grading (tumors)|grade]] | |||
* | **[[Prognosis]] | ||
* | **[[Tumor]] shrinkage following [[chemotherapy]] | ||
*Prognosis | |||
* | === Contrast-Enhanced Ultrasound (CEUS) === | ||
* It can provide information by identifying different and specific enhancement patterns.<ref>{{Cite journal | |||
| author = [[Aurash Naser-Tavakolian]], [[Mittul Gulati]], [[Vinay Duddalwar]], [[Shefali Chopra]], [[Manju Aron]] & [[Hooman Djaladat]] | |||
| title = Contrast-Enhanced Ultrasound of Spermatic Cord and Retroperitoneal Liposarcoma | |||
| journal = [[Ultrasound quarterly]] | |||
| volume = 34 | |||
| issue = 4 | |||
| pages = 292–296 | |||
| year = 2018 | |||
| month = December | |||
| doi = 10.1097/RUQ.0000000000000372 | |||
| pmid = 30020269 | |||
}}</ref> | |||
==References== | ==References== | ||
| Line 21: | Line 35: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 19:23, 29 May 2019
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Liposarcoma other imaging findings |
|
Risk calculators and risk factors for Liposarcoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]; Alejandro Lemor, M.D. [3]Sabawoon Mirwais, M.B.B.S, M.D.[4]
Overview
Positron emission tomography (PET) scan is useful in cases where the liposarcoma is firm, deep, and has a size greater than 3 cm. PET scan may also help evaluate the grade and prognosis of the tumor, as well as its shrinkage following chemotherapy.
Other Imaging Findings
Positron emission tomography (PET)
- Positron emission tomography (PET) is useful to evaluate cases of liposarcoma, especially when the tumor is firm, deep, and has a size greater than 3 cm.[1]
- PET scan is also useful to evaluate:
- Tumor grade
- Prognosis
- Tumor shrinkage following chemotherapy
Contrast-Enhanced Ultrasound (CEUS)
- It can provide information by identifying different and specific enhancement patterns.[2]
References
- ↑ "NCCN Guidelines for Patients - Soft Tissue Sarcoma".
- ↑ Aurash Naser-Tavakolian, Mittul Gulati, Vinay Duddalwar, Shefali Chopra, Manju Aron & Hooman Djaladat (2018). "Contrast-Enhanced Ultrasound of Spermatic Cord and Retroperitoneal Liposarcoma". Ultrasound quarterly. 34 (4): 292–296. doi:10.1097/RUQ.0000000000000372. PMID 30020269. Unknown parameter
|month=ignored (help)